Compound Profiles
Ara 290
Tissue-Protective Peptide | Innate Repair Receptor Agonist
Activates IRR through EPOR/β-common receptor complex, triggering tissue-protective signaling without erythropoietic effects..
CJC-1295 with DAC
Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release
DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..
Combined Organ Load
Frequently Asked Questions
Can I take Ara 290 with CJC-1295 with DAC?
Yes, Ara 290 and CJC-1295 with DAC can generally be taken together. Ara 290 and CJC-1295 with DAC work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.
Is Ara 290 and CJC-1295 with DAC safe together?
Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.
What are the interactions between Ara 290 and CJC-1295 with DAC?
Ara 290 and CJC-1295 with DAC work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.
How should I time Ara 290 and CJC-1295 with DAC?
Ara 290 has a half-life of ~20 minutes (SubQ), ~2 minutes (IV) and CJC-1295 with DAC has a half-life of 6-8 days. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.